Binder Section 3

Respiratory Distress Syndrome (RDS), Pulmonary Transition Failure, Ventilation Management & RHENOVA Lung Protection Program

Program Code: SCF-DBI-NICU-RDS-0001**

Operational Window: Birth → 28 Days (or NICU Discharge)

Primary Objective: Preserve pulmonary biological intelligence while minimizing secondary neurodevelopmental, endothelial, metabolic, and inflammatory injury.

SECTION 3.1

CLINICAL POSITIONING

SCF-DBI Respiratory Philosophy

Traditional RDS management focuses on:

• Oxygenation
• Ventilation
• Surfactant replacement

SCF-DBI Expansion

The respiratory system is viewed as a biologic intelligence interface connecting:

Neurodevelopment

Endothelium

Pulmonary Vasculature

Immune Regulation

Metabolic Adaptation

Growth & Development

Core Principle

Respiratory support should:

Preserve oxygen delivery

while simultaneously

Preserving developmental adaptation

SECTION 3.2

RESPIRATORY FAILURE CLASSIFICATION

Class I

Mild Transition Failure

Characteristics:

• Mild retractions
• Supplemental oxygen requirement
• Stable hemodynamics

Class II

Moderate RDS

Characteristics:

• CPAP dependence
• Increased work of breathing
• Rising oxygen requirement

Class III

Severe RDS

Characteristics:

• Mechanical ventilation
• Significant oxygen requirement
• Respiratory acidosis

Class IV

Critical Respiratory Failure

Characteristics:

• Persistent hypoxemia
• Pulmonary hypertension
• Multi-system destabilization

SECTION 3.3

INITIAL RESPIRATORY ASSESSMENT SOP

Assessment Window

Within:

15 Minutes of NICU Admission

Clinical Assessment

Evaluate:

Respiratory Rate

Work of Breathing

Retractions

Nasal Flaring

Grunting

Apnea

Cyanosis

Physiologic Assessment

Oxygen Saturation

Blood Gas

Lactate

Perfusion

Cerebral Oxygenation

Imaging Assessment

Chest X-Ray

Assess:

• RDS pattern
• Pneumothorax
• Atelectasis
• Pulmonary edema

SECTION 3.4

SCF-DBI RESPIRATORY SURVEILLANCE SYSTEM

Tier 1

Conventional Monitoring

SpO₂

Respiratory Rate

FiO₂

Blood Gases

Tier 2

Pulmonary Intelligence Monitoring

Oxygenation Efficiency

Ventilation Efficiency

Pulmonary Perfusion

Pulmonary Adaptation

Tier 3

RHENOVA Lung Intelligence Monitoring

Neurovascular Oxygen Delivery

Endothelial Stability

Inflammatory Burden

Developmental Lung Integrity

SECTION 3.5

RDS PREVENTATIVE MANAGEMENT SOP

SCF-PCR PREVENTATIVE PHASE

Objective

Prevent progression to severe respiratory failure.

Prevention Bundle

Thermal Stability

Maintain:

36.5–37.5°C

Oxygen Stewardship

Avoid:

Hyperoxia

Hypoxia

Gentle Ventilation Strategy

Avoid:

Barotrauma

Volutrauma

Atelectrauma

Glycocalyx Protection Bundle

Activate immediately.

Purpose:

Prevent endothelial injury.

SECTION 3.6

CPAP MANAGEMENT SOP

Indications

Mild-Moderate RDS

Prematurity

Post-extubation support

Initial Settings

CPAP:

5–6 cmH₂O

Adjust per institutional standards.

Escalation Criteria

Escalate if:

Increasing FiO₂

Rising CO₂

Worsening retractions

Recurrent apnea

RHENOVA Monitoring

Monitor:

Cerebral oxygenation

ANMS respiratory domain

Endothelial stability

SECTION 3.7

SURFACTANT ADMINISTRATION WORKFLOW

Indications

Prematurity

Radiographic RDS

Increasing respiratory support requirements

SCF Goals

Traditional Goal:

Improve oxygenation.

SCF Goal:

Improve oxygenation while minimizing developmental injury.

Procedure Workflow

Step 1

Pre-procedure stabilization

Step 2

Neurodevelopment Preservation Bundle activation

Step 3

Surfactant administration

Step 4

Post-administration monitoring

Assess:

FiO₂ reduction

Cerebral oxygenation

Hemodynamic stability

SECTION 3.8

MECHANICAL VENTILATION ESCALATION PATHWAY

Indications

Persistent respiratory acidosis

Severe apnea

Severe hypoxemia

Pulmonary hypertension

Escalation Sequence

CPAP

↓

NIPPV

↓

Conventional Ventilation

↓

HFOV

↓

HFJV

↓

ECMO Evaluation (where applicable)

RHENOVA Ventilation Philosophy

The least injurious support capable of maintaining physiologic stability should be used.

SECTION 3.9

RHENOVA NEUROVASCULAR LUNG PROTECTION PROTOCOL

Purpose

Prevent lung injury from becoming neurodevelopmental injury.

Core Concept

Lung injury frequently propagates through:

Inflammation

Endothelial injury

Neurovascular disruption

Oxidative stress

Protection Components

Cerebral NIRS

Oxygen stewardship

Inflammatory surveillance

Perfusion optimization

Glycocalyx protection

Monitoring Outputs

Neurovascular Stability Score (NVS)

Endothelial Integrity Index (EII)

Developmental Lung Integrity Score (DLIS)

SECTION 3.10

BRONCHOPULMONARY DYSPLASIA PREVENTION PROGRAM

Purpose

Prevent chronic lung injury.

Risk Factors

Prematurity

Mechanical ventilation

Oxygen toxicity

Inflammation

Infection

Prevention Strategy

Neurodevelopment Preservation Bundle

Protect neural development.

Glycocalyx Protection Bundle

Protect pulmonary endothelium.

Stem Cell Preservation Strategy

Protect developmental lung growth.

Microbiome Stabilization Protocol

Reduce inflammatory burden.

BPD Surveillance Variables

Ventilator Days

FiO₂ Burden

Inflammatory Markers

Growth Velocity

Pulmonary Hypertension Risk

SECTION 3.11

PULMONARY HYPERTENSION SURVEILLANCE

Monitor

Oxygenation

Echocardiography

Lactate

Perfusion

Pulmonary Pressures

Escalation Triggers

Increasing oxygen requirement

Worsening perfusion

Elevated lactate

Right ventricular dysfunction

SECTION 3.12

RESPIRATORY ANMS INTEGRATION

Neuroimmune Domain

Monitor:

IL-6

CRP

Infection burden

Neurovascular Domain

Monitor:

Endothelial biomarkers

Pulmonary perfusion

Neurometabolic Domain

Monitor:

Lactate

Oxygen extraction

Respiratory ANMS Classification

Green

Stable adaptation

Yellow

Compensated respiratory stress

Orange

Threatened respiratory adaptation

Red

Impending respiratory collapse

SECTION 3.13

RESPIRATORY DE-ESCALATION CRITERIA

Criteria

Stable oxygenation

Minimal work of breathing

Stable ANMS

Stable cerebral oxygenation

Improving chest imaging

Adequate growth

Weaning Sequence

HFOV/HFJV

↓

Conventional Ventilation

↓

NIPPV

↓

CPAP

↓

Room Air

SECTION 3.14

RESPIRATORY RECOVERY ENDPOINTS

Physiologic

Stable oxygenation

Stable ventilation

No apnea

Developmental

Stable cerebral oxygenation

Preserved neurologic examination

Endothelial

Stable perfusion

Low inflammatory burden

Growth

Appropriate weight gain

Appropriate developmental progression

PAGE 3 COMPLETION

Next Page (Page 4):

Neonatal Sepsis SOP

Early-Onset Sepsis Workflow

Late-Onset Sepsis Workflow

Neuroimmune Intelligence Monitoring

Glycocalyx Protection Bundle Deployment During Sepsis

RHENOVA Immunologic Self-Tolerance Preservation Program

Septic Shock Prevention & ANMS Escalation Pathway

MASTER REGISTRY INDEX

SCF-DBI-NICU-RDS-0001 — Respiratory Distress Syndrome SOP

SCF-DBI-NICU-VENT-0001 — Ventilation Management SOP

SCF-DBI-NICU-SURF-0001 — Surfactant Administration Workflow

SCF-RHENOVA-NLPP-0001 — Neurovascular Lung Protection Protocol

SCF-DBI-NICU-BPD-0001 — Bronchopulmonary Dysplasia Prevention Program

SCF-DBI-NICU-PHTN-0001 — Pulmonary Hypertension Surveillance Program

SCF-ANMS-RESP-0001 — Respiratory ANMS Monitoring Framework

SCF-NICU-GPB-0001 — Glycocalyx Protection Bundle

SCF-NICU-SCPS-0001 — Stem Cell Preservation Strategy

SCF-RHENOVA-NICU-0001 — Project RHENOVA Neonatal Critical Care Architecture